ISCHEMIC HEART DISEASE DOES NOT MODIFY THE BENEFICIAL EFFECTS OF FINERENONE IN HFMREF/HFPEF: A PRESPECIFIED ANALYSIS OF THE FINEARTS-HF TRIAL